• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Merck entitled to $1.4B in cyberattack case after court rejects insurers'...

cafead

Administrator
Staff member
  • cafead   May 02, 2023 at 11:52: AM
via Merck may finally be entitled to a hefty insurance payout from the high-profile NotPetya cyberattack—if an appeals court ruling stands.

A New Jersey appellate court on Monday ruled that a group of insurers can’t use war as an argument to deny Merck coverage from the notorious cyberattack that afflicted the company and others back in 2017.

article source